Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amniotic and Umbilical Cord Tissue for Multiple Conditions
NCT03899298Phase 1Not yet recruiting
- Sponsor
- R3 Stem Cell
- Start
- Sep 2019
- Primary completion
- Mar 2024
01
Overview
Phase 1, open-label trial of amniotic and umbilical cord tissue in arthritis, sports injury, chronic kidney disease (CKD) and 15 more (7 arms), sponsored by R3 Stem Cell. Primary endpoints: Disabilities of Arm, Shoulder, Hand Questionnaire at 120 months, Sexual Health Inventory for Men Questionnaire at 120 months and 7 more. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
amniotic and umbilical cord tissue
03
Conditions
arthritissports injurychronic kidney disease (CKD)back painCervicalgia
Beyond the preview
Go deeper on NCT03899298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899298.